Southwest Health Equity Research Collaborative
西南健康公平研究合作组织
基本信息
- 批准号:10216873
- 负责人:
- 金额:$ 29.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-20 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAlcohol or Other Drugs useAreaArizonaAttitudeBuprenorphineCOVID-19COVID-19 pandemicCenters for Disease Control and Prevention (U.S.)ClientClinicCommunitiesDataDoseEnvironmentEvaluationEvaluation MethodologyFocus GroupsGoalsGuidelinesHealthHealth Services AccessibilityHome environmentImprove AccessIndividualInstitutionInterventionInterviewInvestigationKnowledgeMethadoneMethodologyMethodsNeeds AssessmentOpiate AddictionOpioidPatientsPerceptionPharmaceutical PreparationsPoliciesProceduresProcess AssessmentProgram DevelopmentProviderRecoveryResearchRiskRural PopulationSamplingScanningServicesSocial DistanceStructureSubstance Use DisorderSupport GroupsSurveysTelemedicineTestingTimeTransportationTravelUnderserved PopulationUnited StatesUnited States National Institutes of HealthValidity and Reliabilitybasebuprenorphine treatmentcare deliverycomparativedesignexperiencehealth equityimprovedmHealthmedication-assisted treatmentminority communitiespandemic diseaseprogramsresponserural arearural underservedsubstance use preventiontelehealthtreatment guidelinestreatment program
项目摘要
During the COVID-19 Pandemic, the United States Drug Enforcement Administration (DEA) temporarily
relaxed restrictions to best serve people in treatment for substance use disorders (SUD) during social
distancing mandates. Changes include allowing longer take home doses of methadone and buprenorphine
rather than coming to the clinic every day (for methadone) or weekly (for buprenorphine), and relaxed
restrictions on telehealth prescribing and treatment. These changes directly and indirectly impact the
approximately 14,500 substance use treatment programs in the United States, but the actual implementation of
the changes is poorly understood. The overarching goals of the proposed project, therefore, are to: (1)
document impacts of relaxed restrictions for telemedicine and mHealth; and (2) assess implementation of MAT
“take-homes” for people in SUD treatment in rural, underserved, and minority communities in Arizona in the
wake of COVID-19. To accomplish these goals, we propose to use Rapid Assessment, Response and
Evaluation (RARE) methods to complete the following specific aims: AIM 1: Identify barriers and facilitators
to successful implementation of telehealth and mHealth for opioid treatment in the context of COVID-
19 restrictions, temporary guideline changes, and “reopening stages”; and AIM 2: Assess
implementation of medication assisted treatment guideline changes and equity in access to “take-
homes” for people in rural and underserved populations. RARE is a well-established mixed-method
approach designed to gather data relevant to institutions and communities as they respond to crisis situations.
RARE assessment involves triangulation of multiple methods to conduct rigorous, locally responsive
assessment and evaluation within a much shorter timeframe than conventional research. We propose to use
RARE methods to collect information about online care delivery program barriers and facilitators, and to
provide local communities with information about local equity, acceptability, and feasibility of potential
telehealth and mHealth interventions. The knowledge to be gained from the proposed project will contribute to
understanding how DEA guideline changes during COVID-19 were implemented and experienced by
stakeholders, providers, and patients in treatment for opioid dependence. The proposed study is expected to
provide in-depth information about providers’ and patients’ experiences of the changes and inform the debate
at the national level about whether policy guideline changes should become permanent after COVID-19 risk
has lessened. There is a pressing need to document experiences of the new guidelines as policymakers
decide whether to make the guidelines permanent. In-depth investigation stands to fills key gaps in
understanding about whether and how increased access to medication-assisted treatment and more access to
treatment via telehealth and mHealth platforms can improve equity for people in rural and underserved areas
who have limited access to care for substance use disorders.
在2019冠状病毒病大流行期间,美国缉毒局(DEA)暂时
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julie Ann Baldwin其他文献
Julie Ann Baldwin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julie Ann Baldwin', 18)}}的其他基金
C-CART: Culturally Centered Addictions Research Training
C-CART:以文化为中心的成瘾研究培训
- 批准号:
10376796 - 财政年份:2021
- 资助金额:
$ 29.31万 - 项目类别:
C-CART: Culturally Centered Addictions Research Training
C-CART:以文化为中心的成瘾研究培训
- 批准号:
10571814 - 财政年份:2021
- 资助金额:
$ 29.31万 - 项目类别:
Factors and Training Approaches that Enhance the Integration of American Indian Culture into Tele-Behavioral Substance Use/Substance Use Disorders Treatment.
促进美洲印第安人文化融入远程行为药物使用/药物使用障碍治疗的因素和培训方法。
- 批准号:
10441963 - 财政年份:2021
- 资助金额:
$ 29.31万 - 项目类别:
C-CART: Culturally Centered Addictions Research Training
C-CART:以文化为中心的成瘾研究培训
- 批准号:
10238380 - 财政年份:2021
- 资助金额:
$ 29.31万 - 项目类别:














{{item.name}}会员




